长风药业(02652)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02652 长风药业

交易中 03-02 15:17:54

38.000

-1.000

-2.56%

最高38.920	最低37.200	成交量11.24万
今开38.580	昨收39.000	日振幅4.41%
总市值156.18亿	流通市值114.76亿	总股本4.11亿
成交额428.65万	换手率0.04%	流通股本3.02亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02652","market":"HK","secType":"STK","nameCN":"长风药业","latestPrice":38,"timestamp":1772435778218,"preClose":39,"halted":0,"volume":112400,"delay":0,"changeRate":-0.02564102564102564,"floatShares":302000000,"shares":411000000,"eps":0.056874,"marketStatus":"交易中","change":-1,"latestTime":"03-02 15:17:54","open":38.58,"high":38.92,"low":37.2,"amount":4286482,"amplitude":0.044103,"askPrice":38.4,"askSize":1500,"bidPrice":38,"bidSize":1500,"shortable":0,"etf":0,"ttmEps":0.073,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1772439000000},"marketStatusCode":2,"adr":0,"listingDate":1759852800000,"exchange":"SEHK","adjPreClose":39,"openAndCloseTimeList":[[1772415000000,1772424000000],[1772427600000,1772438400000]],"volumeRatio":0.346393,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02652","defaultTab":"news","newsList":[{"id":"1111489921","title":"长风药业（02652）回购3.05万股股份，总额约118万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1111489921","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111489921?lang=zh_cn&edition=full","pubTime":"2026-02-27 19:06","pubTimestamp":1772190361,"startTime":"0","endTime":"0","summary":"长风药业股份有限公司于2026年2月27日发布翌日披露报表，公告显示公司当日于香港联交所回购30,500股H股，占回购前已发行股份约0.0101%。回购价格区间为每股38.24港元至38.92港元，合计动用金额约118万港元。回购后，公司已发行股份总数调整为301,727,086股，库藏股数量为496,500股，整体发行股本总数维持在302,223,586股。公司确认已遵守上市规则及相关法律。公告由执行董事及联席公司秘书朱玉玉签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"gpt_icon":0},{"id":"2614183243","title":"长风药业(02652)2月27日斥资118.01万港元回购3.05万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2614183243","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614183243?lang=zh_cn&edition=full","pubTime":"2026-02-27 19:03","pubTimestamp":1772190212,"startTime":"0","endTime":"0","summary":"智通财经APP讯，长风药业(02652)发布公告，于2026年2月27日斥资118.01万港元回购3.05万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1408337.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","02652"],"gpt_icon":0},{"id":"1107844057","title":"长风药业（02652）回购43,000股股份，总额约164万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1107844057","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1107844057?lang=zh_cn&edition=full","pubTime":"2026-02-26 17:51","pubTimestamp":1772099500,"startTime":"0","endTime":"0","summary":"长风药业股份有限公司于2026年2月26日发布翌日披露报表，公告公司当日通过香港联交所回购43,000股H股。每股价格在37.88港元至38.48港元之间，本次交易总额约164万港元。回购后，公司已发行股本降至301,757,586股，库存股增至466,000股，合计股本仍为302,223,586股。本次回购依据2025年12月16日股东大会批准的购回授权进行，可回购股份总数为30,222,358股。截至目前，公司已累计回购466,000股。公告由执行董事及联席公司秘书朱玉玉签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"gpt_icon":0},{"id":"1108164494","title":"长风药业（02652）回购33,000股股份，总金额1,232,250港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1108164494","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1108164494?lang=zh_cn&edition=full","pubTime":"2026-02-25 18:56","pubTimestamp":1772016985,"startTime":"0","endTime":"0","summary":"长风药业股份有限公司于2026年2月25日发布翌日披露报表，宣布通过香港联合交易所回购股份。根据公告，本次回购数量为33,000股，占回购前已发行股份约0.0109%。本次股份回购价格区间为每股36.64港元至37.9港元，合计支付1,232,250港元。回购完成后，公司已发行股份数量变更为301,800,586股，库藏股数量增至423,000股，合计股份数保持在302,223,586股。公司于2025年12月16日通过该回购授权，可回购上限为30,222,358股，截至公告日已累计回购423,000股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"gpt_icon":0},{"id":"2614083686","title":"长风药业(02652)2月25日斥资123.23万港元回购3.3万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2614083686","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614083686?lang=zh_cn&edition=full","pubTime":"2026-02-25 18:52","pubTimestamp":1772016766,"startTime":"0","endTime":"0","summary":"智通财经APP讯，长风药业(02652)发布公告，于2026年2月25日，该公司斥资123.23万港元回购3.3万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1407220.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","02652"],"gpt_icon":0},{"id":"2614761567","title":"长风药业午前涨超4% 自研ICF004新药临床试验申请获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2614761567","media":"新浪港股","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614761567?lang=zh_cn&edition=full","pubTime":"2026-02-25 11:25","pubTimestamp":1771989900,"startTime":"0","endTime":"0","summary":"　　长风药业盘中涨超5%，截至发稿，股价上涨4.16%，现报38.52港元，成交额1386.42万港元。　　2月24日，长风药业发布公告，本公司自主研发的吸入粉雾剂候选药物ICF004（产品）的新药临床试验申请（该申请）已获中国国家药品监督管理局受理。锚定PF-ILD未满足需求，ICF004的研发逻辑立足于“疗效—耐受性”临床矛盾，在现有治疗基础上探索新的递送与作用路径，以期改善治疗窗口和患者获益。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-02-25/doc-inhnyyvu2366690.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1191","02652"],"gpt_icon":0},{"id":"1146441020","title":"长风药业（HKEX: 2652.HK）宣布NMPA受理潜在同类首创吸入干粉制剂ICF004的新药临床试验申请，该药针对PF-ILD领域未满足的临床需求","url":"https://stock-news.laohu8.com/highlight/detail?id=1146441020","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146441020?lang=zh_cn&edition=full","pubTime":"2026-02-25 11:13","pubTimestamp":1771989225,"startTime":"0","endTime":"0","summary":"长风药业（香港交易所代码：2652.HK）宣布，其潜在同类首创（First-in-Class）吸入干粉制剂候选药物ICF004的新药临床试验（IND）申请，已获得国家药品监督管理局（NMPA）的受理。ICF004旨在针对进行性纤维化性间质性肺病（PF-ILD）领域存在的未满足临床需求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BK1191"],"gpt_icon":0},{"id":"2613794808","title":"长风药业(02652)2月24日斥资99.74万港元回购2.7万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2613794808","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613794808?lang=zh_cn&edition=full","pubTime":"2026-02-24 17:49","pubTimestamp":1771926563,"startTime":"0","endTime":"0","summary":"智通财经APP讯，长风药业(02652)发布公告，该公司于2026年2月24日斥资99.74万港元回购2.7万股股份，每股回购价格为36.6-37.18港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1406729.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02652","BK1191"],"gpt_icon":0},{"id":"2613753336","title":"长风药业(02652)：国家药监局受理ICF004的IND申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2613753336","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613753336?lang=zh_cn&edition=full","pubTime":"2026-02-24 06:12","pubTimestamp":1771884770,"startTime":"0","endTime":"0","summary":"智通财经APP讯，长风药业 发布公告，本公司自主研发的吸入粉雾剂候选药物ICF004(产品)的新药临床试验申请(该申请)已获中国国家药品监督管理局受理。ICF004拟用于治疗进行性纤维化间质性肺病，该疾病领域包括特发性肺纤维化及进行性肺纤维化等危及生命的适应症。在已完成的临床前研究中，ICF004经吸入给药后呈现差异化的分布特征，表现为肺组织高暴露量及低全身暴露量。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1406422.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","02652","IND"],"gpt_icon":0},{"id":"2613458226","title":"长风药业于2月20日斥资29.03万港元回购8000股","url":"https://stock-news.laohu8.com/highlight/detail?id=2613458226","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613458226?lang=zh_cn&edition=full","pubTime":"2026-02-22 12:56","pubTimestamp":1771736160,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　长风药业（02652）发布公告，于2026年2月20日斥资29.03万港元回购8000股。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-02-22/doc-inhnsisp8136313.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02652"],"gpt_icon":0},{"id":"1158015190","title":"长风药业（02652）回购8,000股股份，总额约29万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1158015190","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158015190?lang=zh_cn&edition=full","pubTime":"2026-02-20 18:09","pubTimestamp":1771582157,"startTime":"0","endTime":"0","summary":"长风药业股份有限公司于2026年2月20日公告，基于翌日披露报表显示，公司于同日回购8,000股H股股份，约占当日前已发行股本的0.0027%。回购价介乎每股36.08港元至36.50港元，支付总额约290,260港元。公司已发行股本由此减少至301,860,586股，库藏股数目相应增至363,000股，合计已发行股份和库藏股总数为302,223,586股。该项回购依据2025年12月16日通过的购回授权进行，授权购回上限为30,222,358股。长风药业股份有限公司确认已遵守香港联交所上市规则以及相关法律法规。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"gpt_icon":0},{"id":"2612265806","title":"长风药业(02652)2月20日斥资29.03万港元回购8000股","url":"https://stock-news.laohu8.com/highlight/detail?id=2612265806","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612265806?lang=zh_cn&edition=full","pubTime":"2026-02-20 18:08","pubTimestamp":1771582082,"startTime":"0","endTime":"0","summary":"智通财经APP讯，长风药业(02652)发布公告，于2026年2月20日斥资29.03万港元回购8000股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1406080.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02652"],"gpt_icon":0},{"id":"2612237504","title":"港股公告掘金 | 英硅智能、图达通及长风药业获纳入恒生综合指数成份股","url":"https://stock-news.laohu8.com/highlight/detail?id=2612237504","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612237504?lang=zh_cn&edition=full","pubTime":"2026-02-20 09:15","pubTimestamp":1771550100,"startTime":"0","endTime":"0","summary":"【重大事项】英硅智能(03696)获纳入恒生综合指数成份股图达通(02665)获纳入恒生综合指数成份股长风药业(02652)获纳入恒生综合指数成份股翰森制药(03692)：甲磺酸阿美替尼片单药治疗于欧盟获批上市拨康视云-B(02592)：CBT-199新药临床试验申请已生效，临床试验被认定为可安全推进石药集团(01093)：GLP -1/GIP受体双偏向性激动多肽长效注射液在美国获临床试验批准石药","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1405958.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["VT","BK4588","02498","BK1589","HSCI","02652","BK1141","BK1583","02665","BK1191","BK1144","BK1179","BK4585","VXUS","03692","03696"],"gpt_icon":0},{"id":"1124809070","title":"长风药业（02652）回购7.3万股股份，总额约263.7万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1124809070","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1124809070?lang=zh_cn&edition=full","pubTime":"2026-02-16 18:31","pubTimestamp":1771237874,"startTime":"0","endTime":"0","summary":"长风药业股份有限公司于2026年2月16日更新翌日披露报表，公告显示，公司当日回购73,000股H股，约占回购前已发行股本的0.0242%。本次回购最高价为每股36.6港元，最低价为每股35.3港元，总耗资约2,637,170港元。回购完成后，公司已发行股份数量为301,868,586股，库藏股数量增至355,000股，合计302,223,586股。根据公告，本轮回购授权于2025年12月16日获股东大会通过，授权回购总数为30,222,358股。公司表示，上述回购活动已符合香港联交所证券上市规则及相关法律规定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"gpt_icon":0},{"id":"2611107736","title":"长风药业(02652)2月16日耗资约263.72万港元回购7.3万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2611107736","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611107736?lang=zh_cn&edition=full","pubTime":"2026-02-16 18:29","pubTimestamp":1771237780,"startTime":"0","endTime":"0","summary":"智通财经APP讯，长风药业(02652)公布，2026年2月16日耗资约263.72万港元回购7.3万股股份。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1405766.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02652"],"gpt_icon":0},{"id":"2611706621","title":"长风药业(02652)获纳入恒生综合指数 有望于3月9日进入港股通","url":"https://stock-news.laohu8.com/highlight/detail?id=2611706621","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611706621?lang=zh_cn&edition=full","pubTime":"2026-02-16 11:03","pubTimestamp":1771210994,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，2026年2月13日，恒生指数公司公布截至 2025 年 12月31日的恒生指数系列季度检讨结果，长风药业成功获纳入恒生综合指数成份股名单，相关调整将于 2026 年 3 月 6 日(星期五)收市后实施，并于2026年3 月 9 日(星期一)起正式生效。此次获纳入恒生综合指数，标志着公司满足了包括市值、流动性和上市时间等在内的一系列标准，反映了资本市场对公司在吸入制剂细分领域可持续创新潜力和投资价值的高度认可。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1405660.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","HSCI","VT","VXUS","02652","BK4588"],"gpt_icon":0},{"id":"1153072123","title":"长风药业（02652）回购2.75万股股份，总额约96.25万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1153072123","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153072123?lang=zh_cn&edition=full","pubTime":"2026-02-13 18:46","pubTimestamp":1770979580,"startTime":"0","endTime":"0","summary":"长风药业股份有限公司于2026年2月13日公告，已回购普通股合计27,500股，占回购前已发行股份总数约0.0091%。回购价格每股介乎港币34.7元至35.2元，涉资约港币96.249万。公司披露，截至上述回购完成后，其已发行股份总数仍为302,223,586股，其中不包括库藏股的已发行股份数为301,941,586股，库藏股数则由254,500股增至282,000股。公告同时确认，公司在本次回购过程中严格遵守相关上市规则及适用法律。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"gpt_icon":0},{"id":"2611277153","title":"长风药业(02652)2月13日斥资96.25万港元回购2.75万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2611277153","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611277153?lang=zh_cn&edition=full","pubTime":"2026-02-13 18:42","pubTimestamp":1770979351,"startTime":"0","endTime":"0","summary":"智通财经APP讯，长风药业(02652)发布公告，于2026年2月13日斥资96.25万港元回购2.75万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1405292.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02652"],"gpt_icon":0},{"id":"1117168270","title":"长风药业（02652）回购16,500股H股，总额约58万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1117168270","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117168270?lang=zh_cn&edition=full","pubTime":"2026-02-12 18:19","pubTimestamp":1770891591,"startTime":"0","endTime":"0","summary":"长风药业股份有限公司于2026年2月12日发布翌日披露报表，公告显示公司在香港联交所回购16,500股H股，每股价格区间为每股34.76港元至35.58港元，涉资总额约579,920港元。经此次回购后，公司已发行股份数量降至301,969,086股，库藏股数量上升至254,500股，总发行股本仍为302,223,586股。公告同时披露，本次股份购回依据公司于2025年12月16日获通过的购回授权进行，授权范围共计30,222,358股，其中至今已回购254,500股。上述公告由执行董事及联席公司秘书朱玉玉签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"gpt_icon":0},{"id":"2610204259","title":"长风药业02月12日遭主力抛售78.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610204259","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610204259?lang=zh_cn&edition=full","pubTime":"2026-02-12 16:15","pubTimestamp":1770884158,"startTime":"0","endTime":"0","summary":"02月12日, 长风药业股价跌0.84%，报收35.28元，成交金额585.8万元，换手率0.06%，振幅4.22%，量比1.17。长风药业今日主力资金净流出78.3万元，上一交易日主力净流出15.3万元。该股近5个交易日下跌2.80%，主力资金累计净流出44.0万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入194.0万元，其中净流入天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212162150a49b917c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212162150a49b917c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02652"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cfpharmtech.com","stockEarnings":[{"period":"1week","weight":0.0833},{"period":"1month","weight":0.0986},{"period":"3month","weight":0.0269},{"period":"6month","weight":1.6441},{"period":"ytd","weight":0.1143}],"compareEarnings":[{"period":"1week","weight":0.0082},{"period":"1month","weight":-0.043},{"period":"3month","weight":0.0298},{"period":"6month","weight":0.0619},{"period":"1year","weight":0.1228},{"period":"ytd","weight":0.039}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"长风药业股份有限公司是一家专注于吸入技术及吸入药物的研发、生产及商业化的中国公司。该公司的产品组合主要针对呼吸系统疾病，包括哮喘、慢性阻塞性肺病（COPD）和过敏性鼻炎。该公司主要产品包括CF017，即治疗支气管哮喘的吸入用布地奈德混悬液，以及CF018，一种用于治疗过敏性鼻炎的氮䓬斯汀氟替卡松鼻喷雾剂。该公司主要在中国国内市场开展业务。","exchange":"SEHK","name":"长风药业","nameEN":"CF PHARMTECH"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"长风药业(02652)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供长风药业(02652)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"长风药业,02652,长风药业股票,长风药业股票老虎,长风药业股票老虎国际,长风药业行情,长风药业股票行情,长风药业股价,长风药业股市,长风药业股票价格,长风药业股票交易,长风药业股票购买,长风药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"长风药业(02652)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供长风药业(02652)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}